
Kelly O'Donnell @KellyO
FDA committee considering COVID booster issue voted unanimously to support Pfizer booster for those 65 and older and those at higher risk of serious illness. Earlier the panel opposed a broader recommendation for all 16 and older. — PolitiTweet.org